SIGA Technologies Inc. Press Release Archive
- 2010-01-19: Israel Taps SIGA Technologies' ST-246(R) to Combat Smallpox in Simulated Bioterror Attack
- 2009-12-10: SIGA Technologies, Inc. Raises $20.0 Million in a Common Stock Offering
- 2009-11-05: SIGA Presents Update on ST-246(R) Development to the World Health Organization
- 2009-11-02: SIGA Technologies to Discuss Third Quarter 2009 Results of Operations on November 9, 2009
- 2009-09-03: SIGA Technologies Inc. Approved for Nasdaq Global Market Listing
- 2009-09-02: SIGA Technologies Receives a $3 Million Research Grant From the National Institute of Health
- 2009-08-06: SIGA Technologies Reports Operating Results For the Second Quarter of 2009
- 2009-06-29: SIGA Reaches Next Stage in BARDA's RFP Bidding Process
- 2009-06-26: SIGA Technologies, Inc. to be Added to the Russell 3000® and Russell Global® Indices
- 2009-06-15: SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246®
- 2009-06-09: SIGA Proposal to Fund Work on Broad Spectrum Antiviral Selected for Award by Department of Defense
- 2009-05-14: SIGA Technologies Submits Response to BARDA RFP
- 2009-03-30: SIGA Produces FDA Registration Batches of ST-246(r) Drug Product
- 2009-03-12: SIGA to Respond to Barda's Request for Proposal Seeking 1.7 Million Courses of Smallpox Antiviral
- 2009-02-24: ST-246(r) in Combination With the Smallpox Vaccine ACAM2000(tm) Confers Protective Immunity in Primates
- 2009-02-11: BARDA Issues a Presolicitation for Acquisition of a Smallpox Antiviral
- 2009-01-13: SIGA Clarifies European Regulatory Path for Lead Smallpox Anti-viral ST-246
- 2008-12-17: SIGA Completes Manufacture of ST-246 Registration Batches
- 2008-12-02: SIGA Technologies Completes Human Pharmacokinetic Bridging Study Validating Commercial Formulation
- 2008-11-12: SIGA to Present ST-246 to the World Health Organization
- 2008-11-10: SIGA TECHNOLOGIES REPORTS OPERATING RESULTS FOR THE THIRD QUARTER OF 2008
- 2008-11-06: SIGA TECHNOLOGIES TO PRESENT AT THE RODMAN AND RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE
- 2008-11-03: SIGA APPLAUDS EFFORTS TO PROMOTE PRIVATE SECTOR PARTICIPATION IN SMALLPOX BIODEFENSE
- 2008-10-23: SIGA TECHNOLOGIES NAMED TO DELOITTE TRI-STATE AREA TECHNOLOGY FAST 50
- 2008-10-15: SIGA TECHNOLOGIES’ ST-246 NAMED “MOLECULE OF THE MONTH†BY PROUS SCIENCE
- 2008-10-14: SIGA to Present At The Homeland Security Investor Conference
- 2008-09-25: SIGA Technologies to Participate in Committee Meeting for the Institute of Medicine
- 2008-09-18: SIGA Technologies to Attend the HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 and BARDA Industry Day
- 2008-09-18: SIGA Technologies Receives Additional $20 Million From NIH for ST-246 Antiviral Therapeutic Development
- 2008-09-15: NIH Funds SIGA Lassa Antiviral Program
- 2008-09-12: NIH Funds SIGA Dengue Antiviral Program
- 2008-08-12: SIGA Technologies Reports Operating Results for the Second Quarter of 2008
- 2008-05-21: SIGA Advances Dengue Antiviral Program